Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 24, 2023

BUY
$218.65 - $271.46 $182,572 - $226,669
835 New
835 $224,000
Q4 2022

Jan 19, 2023

BUY
$229.03 - $291.01 $191,240 - $242,993
835 New
835 $0
Q2 2022

Jul 19, 2022

BUY
$230.71 - $256.74 $192,642 - $214,377
835 New
835 $203,000
Q1 2022

Apr 18, 2022

SELL
$219.27 - $242.57 $206,552 - $228,500
-942 Closed
0 $0
Q4 2021

Jan 19, 2022

SELL
$198.88 - $227.6 $20,882 - $23,898
-105 Reduced 10.03%
942 $212,000
Q3 2021

Nov 02, 2021

SELL
$212.27 - $248.7 $134,154 - $157,178
-632 Reduced 37.64%
1,047 $223,000
Q1 2021

Apr 19, 2021

BUY
$221.91 - $258.6 $32,176 - $37,497
145 Added 9.45%
1,679 $418,000
Q4 2020

Jan 29, 2021

SELL
$216.38 - $257.67 $134,804 - $160,528
-623 Reduced 28.88%
1,534 $353,000
Q3 2020

Oct 28, 2020

BUY
$234.65 - $260.95 $108,877 - $121,080
464 Added 27.41%
2,157 $548,000
Q2 2020

Jul 29, 2020

SELL
$197.81 - $242.74 $21,165 - $25,973
-107 Reduced 5.94%
1,693 $399,000
Q1 2020

Apr 29, 2020

SELL
$182.24 - $241.7 $16,401 - $21,753
-90 Reduced 4.76%
1,800 $365,000
Q3 2019

Oct 31, 2019

SELL
$174.11 - $208.62 $10,098 - $12,099
-58 Reduced 2.98%
1,890 $366,000
Q2 2019

Aug 01, 2019

SELL
$166.7 - $195.41 $3,500 - $4,103
-21 Reduced 1.07%
1,948 $359,000
Q1 2019

May 07, 2019

SELL
$180.87 - $203.88 $126,609 - $142,716
-700 Reduced 26.23%
1,969 $374,000
Q4 2018

Feb 07, 2019

BUY
$178.4 - $208.25 $122,204 - $142,651
685 Added 34.53%
2,669 $520,000
Q3 2018

Nov 09, 2018

SELL
$185.29 - $208.89 $247,176 - $278,659
-1,334 Reduced 40.2%
1,984 $411,000
Q2 2018

Jul 26, 2018

SELL
$166.05 - $186.51 $3,321 - $3,730
-20 Reduced 0.6%
3,318 $612,000
Q1 2018

Apr 25, 2018

BUY
$169.43 - $198.0 $33,038 - $38,610
195 Added 6.2%
3,338 $569,000
Q4 2017

Jan 26, 2018

SELL
$168.79 - $188.59 $37,133 - $41,489
-220 Reduced 6.54%
3,143 $547,000
Q3 2017

Oct 26, 2017

BUY
$167.29 - $191.0 $562,596 - $642,333
3,363
3,363 $627,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Eagle Ridge Investment Management Portfolio

Follow Eagle Ridge Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Ridge Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Ridge Investment Management with notifications on news.